The synthetic biology concept fluctuates and rises sharply, Tuoxin Pharmaceutical and Xinhua Pharm hit the limit up
The synthetic biology concept has fluctuated and risen sharply, with Tuoxin Pharmaceutical hitting the daily limit, Xinhua Pharm previously hitting the daily limit, and companies like Furuida, Rundu Co., Ltd., Jindawei, and Ruipu Biotech seeing significant gains